Basseterre, St. Kitts, February 12, 2021 (SKNIS): St. Kitts & Nevis’ Chief Medical Officer, Dr. Hazel Laws, said that the procurement in the first instance of 21, 600 doses of the COVID-19 Vaccine, will provide coverage for 20 percent of the national population.
She said this during the National Emergency Operations Center (NEOC) COVID-19 Press Briefing on February 10. “The doses are the product of AstraZeneca and Oxford University vaccines,” she said.
“The start date for delivery can be as early as mid to late February, however, there were some conditions where the specific date of delivery would be dependent on the WHO Emergency Use List Approval Process and some other steps which include our own implementation of our vaccination plan and our regulatory preparedness,” said Dr. Laws.
“It specified that about 25 – 35% of the amount will be supplied in the first quarter and about 65-75% in the second quarter,” she said.
“The data from the clinical trials suggest that it offers a 62 percent efficacy, but the clinical trials have since found that the vaccine had an efficacy of about 82 percent when two doses were given 12 weeks apart,” said Dr. Laws. -30-
Thursday, June 11
Trending
- Prime Minister Drew Pushes Banking Sector to Serve Every Citizen, Regardless of Income
- MP MARSHA HENDERSON GIVES STRONG SUPPORT TO PASSAGE OF EVIDENCE (AMENDMENT) BILL
- EVIDENCE (AMENDMENT) BILL, 2026, MODERNISES DNA EVIDENCE LAW WHILE STRENGTHENING FAIR TRIAL PROTECTIONS IN SAINT KITTS AND NEVIS
- SKN Medicinal Cannabis Authority Launches Responsible Use Campaign
- New Banking Law to Make Financial Services Fairer, Clearer and More Accessible for All
- Prime Minister Drew: Climate Change Demands Urgent Action as Federation Faces Severe Drought
- Reliable 24-Hour Water Supply Remains Government’s National Goal
- SAINT KITTS AND NEVIS PASSES AMENDMENTS TO BANKING ACT STRENGTHENING CONSUMER PROTECTION AND ACCESS TO BANKING SERVICES

